Pulitzer Prize-winning journalist, who covered the moon landing in 1969, dies at 92

In 1984, John Wilford won the Pulitzer Prize for national reporting for articles ‘conveying both the wonder and the reality ...
The Atlanta Voice

Atlanta Falcons Legends support prostate and lung cancer screening initiative

Atlanta Falcons Legends join Emory Healthcare to raise awareness for prostate and lung cancer screening. Early detection can ...

Why Some Doctors Say There Are Cancers That Shouldn’t Be Treated

Statistics show a clear spike in eight cancers in younger people, but that has brought a debate over whether many cases ever ...

Reversing treatment resistance in prostate cancer: Study solves longstanding puzzle in tumor biology

Scientists at the Herbert Irving Comprehensive Cancer Center (HICCC) have discovered a key mechanism that makes prostate cancer cells resistant to the latest drugs used to treat them. Their findings, ...

My shock cancer diagnosis at 42 and the simple test that saved me

Diagnosed with prostate cancer at just 42, CEO Tamas Szabo feared he wouldn't see his children grow up. Now he's fighting to ...

New cancer treatment with fewer side effects to be trialled in UK

A groundbreaking trial for a prostate cancer treatment with fewer side effects has launched in the UK. Backed by the ...

Syncromune®, Inc. Presents Phase 1 Data Highlighting Resolution of Bone Metastases in Metastatic Prostate Cancer Patients at Society of Urological Oncology 26th Annual Meeting

FORT LAUDERDALE, Fla. and WEST DES MOINES, Iowa, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Syncromune®, Inc., a clinical-stage biopharmaceutical ...

Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Locally Recurrent Prostate Cancer

We are excited to bring the Alpha DaRT technology to prostate cancer patients in the U.S.,” said Dr. Robert B. Den, Alpha Tau ...

Cancer-Detecting Blood Tests Are on the Rise. Do They Work?

The tests have not been approved by federal regulators, but that hasn’t stopped patients from wanting them — and doctors from worrying.

Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Significantly Reduces PSA Levels in Human Prostate Cancer Cells

PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner. MIAMI, FLORIDA / ACCESS Newswire / November ...